Compare IMNM & CWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMNM | CWK |
|---|---|---|
| Founded | 2006 | 1784 |
| Country | United States | United States |
| Employees | N/A | 53000 |
| Industry | Medicinal Chemicals and Botanical Products | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 3.1B |
| IPO Year | 2020 | 2018 |
| Metric | IMNM | CWK |
|---|---|---|
| Price | $19.35 | $13.00 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 7 |
| Target Price | ★ $32.80 | $17.64 |
| AVG Volume (30 Days) | 1.3M | ★ 1.9M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 51.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $6,941,000.00 | ★ $10,288,200,000.00 |
| Revenue This Year | N/A | $6.87 |
| Revenue Next Year | $1,127.34 | $5.98 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 8.91 |
| 52 Week Low | $7.96 | $10.94 |
| 52 Week High | $27.65 | $17.40 |
| Indicator | IMNM | CWK |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 49.56 |
| Support Level | $19.28 | $11.78 |
| Resistance Level | $23.00 | $14.22 |
| Average True Range (ATR) | 0.84 | 0.51 |
| MACD | 0.21 | -0.01 |
| Stochastic Oscillator | 49.16 | 29.10 |
Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.
Cushman & Wakefield is one of the largest commercial real estate services firms in the world and is headquartered in Chicago. The firm provides a broad suite of real estate-related services to owners, tenants, and investors. These include brokerage services for leasing and capital markets sales as well as advisory services such as valuation, project management, and facilities management.